Mar 2024 -  :  Associate Professor, Dept. of Life Science, Dongguk University

Feb 2024 -  :  Department Chair, Dept. of Life Science, Dongguk University

Mar 2022 -  :  Joint Appointment Professor, Department of Artificial Intelligence, Dongguk University

Mar 2020 - Feb 2024:  Assistant Professor, Dept. of Life Science, Dongguk University

Oct 2016 - Feb 2020: Research Assistant Professor, Catholic Precision Medicine Research Center, The Catholic University of Korea School of Medicine

Apr 2014 - Nov 2016: Assistant Professor, Dept. of Biological Science, Sangji University

Mar 2013 - Mar 2014: Post-Doc, Information & Electronics Research Institute, KAIST

Mar 2005 - Feb 2013: Ph. D., Dept. of Bio and Brain Enginnering, KAIST

Mar 2002 - Feb 2005: B.S., Dept. of BioSystems, KAIST

2024: Macrogen Young Bioinformatician Award

2021: Commendation from the President of the Korea Health Industry Development Institute (KHIDI)

2017: Best paper award, Bronze, InCoB 2017,  APBioNET

2014: Best paper award, KCC 2014, Korean Institute of Information Scientists and Engineers (KIISE)

2007: Best paper award, BIOINFO 2007, Korea Society of Bioinformatics

2005: Kim Bo-jung Basic Science Scholarship, KAIST

2022-  : Review editor for Synthetic Biology, Frontiers in Bioengineering and Biotechnology

2022-  : Operations committee, Korean Society for Biochemistry and Molecular Biology (KSBMB)

2021 -  : Operations committee, Korean Society for Bioinformatics (KSBi)

2017 -  : Operations committee, Korea Genome Organization (KOGO)

2021- 2024   : Review Board (RB), National Research Foundation of Korea (NRF) 

2020 :  Program committee, IEEE BIBM 2020

2018 :  Local organizing committee, HCA Asia 2018

B.S. 2008.03-2012.08 Bio and Brain Engineering, KAIST, Daejeon, Korea

M.S. 2012.09-2014.02 Bio and Brain Engineering, KAIST, Daejeon, Korea

Ph.D. 2014.03-2022.02 Bio and Brain Engineering, KAIST, Daejeon, Korea

2022: Standigm Outstanding Paper Award at BIOINFO 2022 

1. Yang D, et al. 2022. DeepLUCIA: predicting tissue-specific chromatin loops using Deep Learning‑based Universal Chromatin Interaction Annotator. Bioinformatics 38(14):3501–3512 

2. Yang D, et al. 2018. 3DIV: A 3D‑genome Interaction Viewer and database. Nucleic Acids Res 46(D1):D52–D57 

3. Jung I, Schmitt A, Diao Y, Lee AJ, Liu T, Yang D, Tan C, Eom J, Chan M, Chee S, Chiang Z, Kim C, Masliah E, Barr CL, Li B, Kuan S, Kim D, Ren B, et al. 2019. A compendium of promoter‑centered long‑range chromatin interactions in the human genome. Nat Genet 51(10):1442–1449 

B.S. Department of Chemistry, Dongguk univ, Seoul, Korea

M.S. Department of Chemistry, Dongguk univ, Seoul, Korea

Ph.D.  Department of Chemistry and Nanoscience, Ewha Womans univ, Seoul, Korea

2023: Best Research Award, Korea Basic Science Institute (KBSI)

2022: Best Paper Award, Korea Basic Science Institute (KBSI)

2019: Best Oral Presenter Award, Korea Chemistry Society (KCS)

1. Oh M, Jang SY, Lee JY, Kim JW, et al. 2023. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat Commun 14(1):5728.

2. Go M, Shin E, Jang SY, Nam M, et al. 2022. BCAT1 promotes osteoclast maturation by regulating branched-chain amino acid metabolism. Exp Mol Med 54(6):825–833. 

3. Jang SY, Jung Y, Lee DH, Hwang GS. 2022. NMR-based metabolomic analysis of human plasma to examine the effect of exposure to persistent organic pollutants. Chemosphere 307(Pt 4):135963. 

4. Lee JY, Nam M, Son HY, Hyun K, Jang SY, et al. 2020. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A 117(51):32433–32442. 

B.S. Department of Biological Sciences, Sookmyung Women’s University, Seoul, Korea

Ph.D. Department of Biological Sciences, Sookmyung Women’s University, Seoul, Korea 

2025: KOGO Young scientist best presentation award

1. Han SH, Ko JY, Jung S, Oh S, Kim DY, Kang E, Kim MS, Chun KH, Yoo KH, Park JH, et al. 2024. VIM‑AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma. Exp Mol Med 56(12):2617–2630

2. Oh S, Baek YH, Jung S, Yoon S, Kang B, Han SH, Park G, Ko JY, Han SY, Jeong JS, Cho JH, Roh YH, Lee SW, Choi GB, Lee YS, Kim W, Seong RH, Park JH, Lee YS, Yoo KH, et al. 2024. Identification of signature gene set as highly accurate determination of metabolic dysfunction‑associated steatotic liver disease progression. Clin Mol Hepatol 30(2):247–262